359 related articles for article (PubMed ID: 27306792)
1. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.
Hoogstins CE; Tummers QR; Gaarenstroom KN; de Kroon CD; Trimbos JB; Bosse T; Smit VT; Vuyk J; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
Clin Cancer Res; 2016 Jun; 22(12):2929-38. PubMed ID: 27306792
[TBL] [Abstract][Full Text] [Related]
2. A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
Randall LM; Wenham RM; Low PS; Dowdy SC; Tanyi JL
Gynecol Oncol; 2019 Oct; 155(1):63-68. PubMed ID: 31362825
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
[TBL] [Abstract][Full Text] [Related]
4. The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review.
de Jong JM; Hoogendam JP; Braat AJAT; Zweemer RP; Gerestein CG
Gynecol Oncol; 2021 Aug; 162(2):517-525. PubMed ID: 34053747
[TBL] [Abstract][Full Text] [Related]
5. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
6. The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.
Tummers QR; Hoogstins CE; Peters AA; de Kroon CD; Trimbos JB; van de Velde CJ; Frangioni JV; Vahrmeijer AL; Gaarenstroom KN
PLoS One; 2015; 10(6):e0129766. PubMed ID: 26110901
[TBL] [Abstract][Full Text] [Related]
7. Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.
Bacalbasa N; Dima S; Balescu I; David L; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4099-104. PubMed ID: 26124361
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
Paik ES; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS
J Gynecol Oncol; 2016 May; 27(3):e24. PubMed ID: 27029745
[TBL] [Abstract][Full Text] [Related]
9. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
Chesnais M; Lecuru F; Mimouni M; Ngo C; Fauconnier A; Huchon C
PLoS One; 2017; 12(11):e0187245. PubMed ID: 29117194
[TBL] [Abstract][Full Text] [Related]
10. A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
Tanyi JL; Randall LM; Chambers SK; Butler KA; Winer IS; Langstraat CL; Han ES; Vahrmeijer AL; Chon HS; Morgan MA; Powell MA; Tseng JH; Lopez AS; Wenham RM
J Clin Oncol; 2023 Jan; 41(2):276-284. PubMed ID: 36070540
[TBL] [Abstract][Full Text] [Related]
11. Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.
Peng P; Zhu ZH; Zhong ZJ; Zheng K; Yang JX; Cao DY; Shen K
Br J Radiol; 2015 Aug; 88(1052):20150109. PubMed ID: 25989698
[TBL] [Abstract][Full Text] [Related]
12. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
[TBL] [Abstract][Full Text] [Related]
13. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study.
Harlaar NJ; Koller M; de Jongh SJ; van Leeuwen BL; Hemmer PH; Kruijff S; van Ginkel RJ; Been LB; de Jong JS; Kats-Ugurlu G; Linssen MD; Jorritsma-Smit A; van Oosten M; Nagengast WB; Ntziachristos V; van Dam GM
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):283-290. PubMed ID: 28404198
[TBL] [Abstract][Full Text] [Related]
14. CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model.
Kleinmanns K; Fosse V; Davidson B; de Jalón EG; Tenstad O; Bjørge L; McCormack E
EBioMedicine; 2020 Jun; 56():102783. PubMed ID: 32454402
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a Short Versus Long Stokes Shift Near-Infrared Dye During Intraoperative Molecular Imaging.
Corbett CJ; Frenzel Sulyok LG; Predina JD; Newton AD; Bryski MG; Xia L; Stadanlick J; Shin MH; Mahalingam SM; Low PS; Singhal S
Mol Imaging Biol; 2020 Feb; 22(1):144-155. PubMed ID: 31820349
[TBL] [Abstract][Full Text] [Related]
16. Surgery for advanced epithelial ovarian cancer.
Hacker NF; Rao A
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():71-87. PubMed ID: 27884789
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes.
Fagotti A; Costantini B; Gallotta V; Cianci S; Ronsini C; Petrillo M; Pacciani M; Scambia G; Fanfani F
J Minim Invasive Gynecol; 2015; 22(3):428-32. PubMed ID: 25461683
[TBL] [Abstract][Full Text] [Related]
18. Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.
Eriksson AGZ; Graul A; Yu MC; Halko A; Chi DS; Zivanovic O; Gardner GJ; Sonoda Y; Barakat RR; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2017 Aug; 146(2):263-267. PubMed ID: 28527673
[TBL] [Abstract][Full Text] [Related]
19. Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
Minaguchi T; Satoh T; Matsumoto K; Sakurai M; Ochi H; Onuki M; Oki A; Yoshikawa H
Int J Clin Oncol; 2016 Jun; 21(3):573-9. PubMed ID: 26475355
[TBL] [Abstract][Full Text] [Related]
20. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
